In the context of our finding of a potential role for leptin resistance in increasing BC risk, the following mechanism is suggested: Firstly, the presence of the G allele of rs1137101 results in an increase in the serum levels of leptin, which is secreted in larger amounts in order to compensate for the reduced activity of the leptin receptor. The gene discussed is LEP; the disease is breast cancer.